Disseminated cryptococcosis

Disseminated cryptococcosis is a life-threatening systemic mycosis resulting from hematogenous dissemination of *Cryptococcus* spp., primarily following inhalation of environmental yeast cells. The disease is defined by the presence of clinical or radiological evidence of involvement beyond the lungs—including meningoencephalitis, disseminated organ infiltration, or extrapulmonary manifestations—in the absence of localized pulmonary disease alone. It is considered a major opportunistic infection among immunocompromised hosts, particularly those with CD4+ T-cell counts <100/μL.

The syndrome often presents with insidious onset of headache, fever, and altered mental status, reflecting central nervous system involvement; meningitis is the most common manifestation. Pulmonary symptoms may be absent or mild, and extraneural dissemination can involve skin, bone, liver, or spleen. In immunocompetent individuals, disease is rare and usually self-limited; however, in immunosuppressed patients, progression is rapid and associated with high case-fatality rates, especially without early antifungal therapy. Complications include increased intracranial pressure, hydrocephalus, and post-treatment relapse.

Disseminated cryptococcosis is globally distributed but disproportionately affects regions with high HIV burden, particularly sub-Saharan Africa, where it accounts for a substantial proportion of AIDS-defining illnesses. In Southeast Asia, *Talaromyces marneffei* (formerly *Penicillium marneffei*)—a distinct thermally dimorphic fungus—is the primary etiologic agent of disseminated mycosis in immunocompromised individuals, especially those with HIV/AIDS. Incidence has risen in parallel with increasing HIV prevalence in endemic zones, though precise global incidence data remain sparse due to underdiagnosis and lack of routine fungal culture capacity.

Transmission occurs via inhalation of aerosolized fungal spores from contaminated soil or bird droppings, particularly in environments with high organic matter and pigeon excreta. Human-to-human transmission does not occur. The organism is not known to persist in the human body as a commensal; rather, infection results from exposure to environmental reservoirs followed by reactivation or primary acquisition in susceptible hosts.

High-risk groups include individuals with advanced HIV/AIDS (particularly with CD4+ T-cell counts <100/μL), solid organ transplant recipients, patients on long-term corticosteroid or biologic therapy, and those with hematologic malignancies or other forms of immunosuppression. In Southeast Asia, *Talaromyces marneffei* infection is strongly associated with HIV co-infection, while *Cryptococcus* species are more commonly linked to HIV in sub-Saharan Africa and parts of Latin America.

Primary prevention focuses on reducing exposure in endemic areas through avoidance of high-risk environments (e.g., bird-infested structures), use of respiratory protection during construction or agricultural work, and implementation of antiretroviral therapy to preserve immune function in at-risk populations. Secondary prevention includes prophylactic antifungal therapy (e.g., fluconazole) for individuals with CD4+ counts <100/μL in high-burden settings, although specific guidelines are not provided in the available sources.

Surveillance of disseminated cryptococcosis should prioritize cases with documented CNS involvement or multi-organ dissemination, especially among persons with known HIV infection or other immunosuppressive conditions. Case reporting should include CD4 count, antiretroviral status, and availability of diagnostic testing (e.g., CSF India ink, cryptococcal antigen, culture). Due to overlapping clinical presentations with other opportunistic infections, laboratory confirmation remains essential for accurate surveillance and outbreak detection.

1. 1 Wikidata. Disseminated Cryptococcosis.
2. 2 Wikipedia. Talaromyces marneffei.

ICD-10

ICD-11

Total cases

1K

Peak month

2024-03

Coverage

1 reporting countries · 2014-09-19 → 2026-05-02